[go: up one dir, main page]

AU2003259198A8 - Method and composition for treating and preventing influenza infection and symptoms thereof - Google Patents

Method and composition for treating and preventing influenza infection and symptoms thereof

Info

Publication number
AU2003259198A8
AU2003259198A8 AU2003259198A AU2003259198A AU2003259198A8 AU 2003259198 A8 AU2003259198 A8 AU 2003259198A8 AU 2003259198 A AU2003259198 A AU 2003259198A AU 2003259198 A AU2003259198 A AU 2003259198A AU 2003259198 A8 AU2003259198 A8 AU 2003259198A8
Authority
AU
Australia
Prior art keywords
symptoms
treating
composition
influenza infection
preventing influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003259198A
Other versions
AU2003259198A1 (en
Inventor
Kenton Zavitz
Scott Morham
Adrian Hobden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myriad Genetics Inc
Original Assignee
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc filed Critical Myriad Genetics Inc
Publication of AU2003259198A1 publication Critical patent/AU2003259198A1/en
Publication of AU2003259198A8 publication Critical patent/AU2003259198A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003259198A 2002-07-19 2003-07-21 Method and composition for treating and preventing influenza infection and symptoms thereof Abandoned AU2003259198A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39733902P 2002-07-19 2002-07-19
US60/397,339 2002-07-19
US45300403P 2003-03-07 2003-03-07
US60/453,004 2003-03-07
PCT/US2003/022836 WO2004009028A2 (en) 2002-07-19 2003-07-21 Method and composition for treating and preventing influenza infection and symptoms thereof

Publications (2)

Publication Number Publication Date
AU2003259198A1 AU2003259198A1 (en) 2004-02-09
AU2003259198A8 true AU2003259198A8 (en) 2004-02-09

Family

ID=30773014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259198A Abandoned AU2003259198A1 (en) 2002-07-19 2003-07-21 Method and composition for treating and preventing influenza infection and symptoms thereof

Country Status (2)

Country Link
AU (1) AU2003259198A1 (en)
WO (1) WO2004009028A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074303A2 (en) * 2005-01-05 2006-07-13 Philadelphia Health And Education Corporation Delivery vehicles, bioactive substances and viral vaccines
EP2080768A1 (en) * 2008-01-21 2009-07-22 Freie Universität Berlin Method for studying virus particle release
WO2011088451A1 (en) * 2010-01-15 2011-07-21 Novavax, Inc. Uses of influenza virus-like particles (vlps) for characterization of neuraminidase and hemagglutinin activity
US12059413B2 (en) 2016-11-02 2024-08-13 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
EP3543698A1 (en) * 2018-03-20 2019-09-25 Helmholtz-Zentrum für Infektionsforschung GmbH Method for determining vaccine efficacy in an individual and means therefore

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783939B2 (en) * 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines

Also Published As

Publication number Publication date
AU2003259198A1 (en) 2004-02-09
WO2004009028A2 (en) 2004-01-29
WO2004009028A3 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
IL160933A0 (en) Methods and compositions for treating ?cap associated diseases
GB0110288D0 (en) Composition and treatment method
TWI315986B (en) Compositions and methods for treating or preventing pneumococcal infection
IL164219A0 (en) Method for treating and preventing hyparathyroidism
IL160010A0 (en) Methods and compositions for treating fungal infections
AU2002367023A8 (en) Compositions and methods for treating heart failure
EP1651255A4 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
SG118236A1 (en) Compositions and methods for treating coronavirus infection and SARS
AU2002365057A8 (en) Compositions and methods for treating heart failure
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
AU2003296963A8 (en) Methods and compositions for treating and preventing ear infections
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
AU2003213048A8 (en) Composition and method for protecting labile active components
PL373593A1 (en) Androgen pharmaceutical composition and method for treating depression
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003258176A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2003254129A8 (en) Method and composition for treating and preventing hepatitis b infection and symptoms thereof
AU2003237088A8 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU2003303948A8 (en) Compositions and methods for preventing infection
AU2003275069A8 (en) Compositions and methods for preventing infection
AU2003275433A8 (en) Compositions and methods for treating pain
AU2003256678A8 (en) Method and composition for treating and preventing hepatitis c infection
AU2003258177A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase